Control of CNS Functions by RNA-binding Proteins in Neurological Diseases

Overview

Journal Curr Pharmacol Rep

Date 2018 Nov 10

PMID 30410853

Citations 7

Authors

Yijing Zhou

Fengping Dong

Yingwei Mao

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: This review summarizes recent studies on the molecular mechanisms of RNA binding proteins (RBPs) that control neurological functions and pathogenesis in various neurodevelopmental and neurodegenerative diseases, including autism spectrum disorders, schizophrenia, Alzheimer's disease, amyotrophic lateral sclerosis, frontotemporal dementia, and spinocerebellar ataxia.

Recent Findings: RBPs are critical players in gene expression that regulate every step of posttranscriptional modifications. Recent genome-wide approaches revealed that many proteins associate with RNA, but do not contain any known RNA binding motifs. Additionally, many causal and risk genes of neurodevelopmental and neurodegenerative diseases are RBPs. Development of high-throughput sequencing methods has mapped out the fingerprints of RBPs on transcripts and provides unprecedented potential to discover new mechanisms of neurological diseases. Insights into how RBPs modulate neural development are important for designing effective therapies for numerous neurodevelopmental and neurodegenerative diseases.

Summary: RBPs have diverse mechanisms for modulating RNA processing and, thereby, controlling neurogenesis. Understanding the role of disease-associated RBPs in neurogenesis is vital for developing novel treatments for neurological diseases.

Citing Articles

The Exon Junction Complex Factor RBM8A in Glial Fibrillary Acid Protein-Expressing Astrocytes Modulates Locomotion Behaviors.

Asthana S, Mott J, Tong M, Pei Z, Mao Y Cells. 2024; 13(6.

PMID: 38534343 PMC: 10968791. DOI: 10.3390/cells13060498.

It is not just about transcription: involvement of brain RNA splicing in substance use disorders.

Carvalho L, Lasek A J Neural Transm (Vienna). 2024; 131(5):495-503.

PMID: 38396082 PMC: 11055753. DOI: 10.1007/s00702-024-02740-y.

Evidence of shared transcriptomic dysregulation of HNRNPU-related disorder between human organoids and embryonic mice.

Ressler A, Sampaio G, Dugger S, Sapir T, Krizay D, Boland M iScience. 2023; 26(1):105797.

PMID: 36594023 PMC: 9804147. DOI: 10.1016/j.isci.2022.105797.

PRP8-Induced CircMaml2 Facilitates the Healing of the Intestinal Mucosa via Recruiting PTBP1 and Regulating Sec62.

Deng Y, Xu X, Meng F, Lou J, Liao Y, Li Q Cells. 2022; 11(21).

PMID: 36359856 PMC: 9654005. DOI: 10.3390/cells11213460.

Cytoplasmic Expression of the ALS/FTD-Related Protein TDP-43 Decreases Global Translation Both and .

Charif S, Luchelli L, Vila A, Blaustein M, Igaz L Front Cell Neurosci. 2020; 14:594561.

PMID: 33363456 PMC: 7752804. DOI: 10.3389/fncel.2020.594561.

References

Deans P, Raval P, Sellers K, Gatford N, Halai S, Duarte R . Psychosis Risk Candidate ZNF804A Localizes to Synapses and Regulates Neurite Formation and Dendritic Spine Structure. Biol Psychiatry. 2016; 82(1):49-61. PMC: 5482321. DOI: 10.1016/j.biopsych.2016.08.038. View

Murakami T, Qamar S, Lin J, Kaminski Schierle G, Rees E, Miyashita A . ALS/FTD Mutation-Induced Phase Transition of FUS Liquid Droplets and Reversible Hydrogels into Irreversible Hydrogels Impairs RNP Granule Function. Neuron. 2015; 88(4):678-90. PMC: 4660210. DOI: 10.1016/j.neuron.2015.10.030. View

Gantois I, Khoutorsky A, Popic J, Aguilar-Valles A, Freemantle E, Cao R . Metformin ameliorates core deficits in a mouse model of fragile X syndrome. Nat Med. 2017; 23(6):674-677. DOI: 10.1038/nm.4335. View

Neves-Pereira M, Muller B, Massie D, Williams J, OBrien P, Hughes A . Deregulation of EIF4E: a novel mechanism for autism. J Med Genet. 2009; 46(11):759-65. DOI: 10.1136/jmg.2009.066852. View

Cousijn H, Tunbridge E, Rolinski M, Wallis G, Colclough G, Woolrich M . Modulation of hippocampal theta and hippocampal-prefrontal cortex function by a schizophrenia risk gene. Hum Brain Mapp. 2015; 36(6):2387-95. PMC: 4672713. DOI: 10.1002/hbm.22778. View

Honda D, Ishigaki S, Iguchi Y, Fujioka Y, Udagawa T, Masuda A . The ALS/FTLD-related RNA-binding proteins TDP-43 and FUS have common downstream RNA targets in cortical neurons. FEBS Open Bio. 2013; 4:1-10. PMC: 3851184. DOI: 10.1016/j.fob.2013.11.001. View

Kuswanto C, Woon P, Zheng X, Qiu A, Sitoh Y, Chan Y . Genome-wide supported psychosis risk variant in ZNF804A gene and impact on cortico-limbic WM integrity in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2012; 159B(3):255-62. DOI: 10.1002/ajmg.b.32032. View

Ingram M, Wozniak E, Duvick L, Yang R, Bergmann P, Carson R . Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways. Neuron. 2016; 89(6):1194-1207. PMC: 4795980. DOI: 10.1016/j.neuron.2016.02.011. View

Nicodemus K, Hargreaves A, Morris D, Anney R, Gill M, Corvin A . Variability in working memory performance explained by epistasis vs polygenic scores in the ZNF804A pathway. JAMA Psychiatry. 2014; 71(7):778-785. PMC: 4337973. DOI: 10.1001/jamapsychiatry.2014.528. View

10.

Andersen C, Ballut L, Johansen J, Chamieh H, Nielsen K, Oliveira C . Structure of the exon junction core complex with a trapped DEAD-box ATPase bound to RNA. Science. 2006; 313(5795):1968-72. DOI: 10.1126/science.1131981. View

11.

Faghihi M, Modarresi F, Khalil A, Wood D, Sahagan B, Morgan T . Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008; 14(7):723-30. PMC: 2826895. DOI: 10.1038/nm1784. View

12.

Xu Q, Xiong Y, Yuan C, Liu F, Zhao F, Shen J . ZNF804A rs1344706 interacts with COMT rs4680 to affect prefrontal volume in healthy adults. Brain Imaging Behav. 2017; 12(1):13-19. DOI: 10.1007/s11682-016-9671-x. View

13.

Wickramasinghe A, Tulloch A, Hayes R, Chang C, Broadbent M, Di Forti M . Associations between the schizophrenia susceptibility gene ZNF804A and clinical outcomes in psychosis. Transl Psychiatry. 2015; 5:e698. PMC: 5068593. DOI: 10.1038/tp.2015.198. View

14.

Kendirgi F, Barry D, Griffis E, Powers M, Wente S . An essential role for hGle1 nucleocytoplasmic shuttling in mRNA export. J Cell Biol. 2003; 160(7):1029-40. PMC: 2172758. DOI: 10.1083/jcb.200211081. View

15.

Millar J, Christie S, Semple C, Porteous D . Chromosomal location and genomic structure of the human translin-associated factor X gene (TRAX; TSNAX) revealed by intergenic splicing to DISC1, a gene disrupted by a translocation segregating with schizophrenia. Genomics. 2000; 67(1):69-77. DOI: 10.1006/geno.2000.6239. View

16.

Jolly L, Homan C, Jacob R, Barry S, Gecz J . The UPF3B gene, implicated in intellectual disability, autism, ADHD and childhood onset schizophrenia regulates neural progenitor cell behaviour and neuronal outgrowth. Hum Mol Genet. 2013; 22(23):4673-87. DOI: 10.1093/hmg/ddt315. View

17.

Mao Y, Ge X, Frank C, Madison J, Koehler A, Doud M . Disrupted in schizophrenia 1 regulates neuronal progenitor proliferation via modulation of GSK3beta/beta-catenin signaling. Cell. 2009; 136(6):1017-31. PMC: 2704382. DOI: 10.1016/j.cell.2008.12.044. View

18.

Walker C, Herranz-Martin S, Karyka E, Liao C, Lewis K, Elsayed W . C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci. 2017; 20(9):1225-1235. PMC: 5578434. DOI: 10.1038/nn.4604. View

19.

Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Iwase M, Iike N . The impact of a genome-wide supported psychosis variant in the ZNF804A gene on memory function in schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2010; 153B(8):1459-64. DOI: 10.1002/ajmg.b.31123. View

20.

Sun S, Ling S, Qiu J, Albuquerque C, Zhou Y, Tokunaga S . ALS-causative mutations in FUS/TLS confer gain and loss of function by altered association with SMN and U1-snRNP. Nat Commun. 2015; 6:6171. PMC: 4338613. DOI: 10.1038/ncomms7171. View